BRCA2 DNA repair errors implicated in infertility
BRCA2 mutations may be implicated in infertility, as well as increasing cancer risk, according to new research...
Molly Godfrey was a Volunteer Writer at BioNews, having originally joined the publication under the auspices of its writing scheme. Molly currently works as a clinical scientist in genomics at the North West Genomics Laboratory Hub. She obtained her PhD in Cell and Molecular Biology at Cancer Research UK's London Research Institute (now subsumed into The Francis Crick Institute), where her work made use of budding yeast to further our understanding of the molecular mechanisms controlling cell replication. Previously, she studied Biological Sciences at the University of Warwick.w
BRCA2 mutations may be implicated in infertility, as well as increasing cancer risk, according to new research...
A baby has become the first NHS patient to receive gene therapy for spinal muscular atrophy...
A clinical trial for a new gene therapy approach to treat sickle cell disease has been approved to proceed by the US Food and Drug Administration...
Researchers comparing different methods of genome editing have found that in some contexts, TALENs work more efficiently than CRISPR/Cas9...
Women who have received fertility treatment are not at increased risk of ovarian cancer, according to a new study...
Embryonic haematopoietic stem cells (HCSs) have a much higher regenerative capacity than umbilical cord HSCs, scientists have discovered...
Screening all women over 30 for the most common breast and ovarian cancer causing mutations could prevent millions of cancer deaths worldwide, according to a new study...
An association between patient blood type and severity of COVID-19 symptoms has been detected in preliminary studies...
The world's largest publicly available dataset of human genomic variation has returned its first results in the form of seven simultaneously published studies....
New research, in HIV positive patients being treated for blood cancer, has identified a critical time window after donor transplantation, during which the expanding donor cells are particularly vulnerable to being infected with HIV.
Subscribe for free to what PET does best – informing you of the latest in fertility, genomics and embryo research.